In vitro antifungal activity of luliconazole against nondermatophytic moulds.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
01 Jul 2020
Historique:
received: 06 08 2019
revised: 04 10 2019
accepted: 11 11 2019
pubmed: 24 11 2019
medline: 26 1 2021
entrez: 24 11 2019
Statut: ppublish

Résumé

In vitro antifungal activity of luliconazole against nondermatophytic moulds causing superficial infections was compared with that of five classes of 12 topical and systemic drugs. The minimum inhibitory concentration (MIC) of the drugs against the genera of Neoscytalidium, Fusarium, Aspergillus, Scedosporium, and Alternaria was measured via modified microdilution method. In results, the nondermatophytic moulds were found to be less susceptible to drugs to which Neoscytalidium spp. and Fusarium spp. were typically drug resistant. However, luliconazole was effective against all the genera tested, including afore-mentioned two species, and had the lowest MICs among the drugs tested.

Identifiants

pubmed: 31758690
pii: 5638893
doi: 10.1093/mmy/myz117
doi:

Substances chimiques

Antifungal Agents 0
Imidazoles 0
Morpholines 0
Triazoles 0
Itraconazole 304NUG5GF4
latoconazole 4E7858311F
Miconazole 7NNO0D7S5M
Amphotericin B 7XU7A7DROE
Fluconazole 8VZV102JFY
amorolfine AB0BHP2FH0
Clotrimazole G07GZ97H65
Terbinafine G7RIW8S0XP
efinaconazole J82SB7FXWB
Voriconazole JFU09I87TR
bifonazole QYJ305Z91O
Ketoconazole R9400W927I
luliconazole RE91AN4S8G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

703-706

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Jun Maeda (J)

Research Center, Nihon Nohyaku Co., Ltd.

Hiroyasu Koga (H)

Sato Pharmaceutical Co., Ltd.

Kou Yuasa (K)

Research Center, Nihon Nohyaku Co., Ltd.

Daisuke Neki (D)

Research Center, Nihon Nohyaku Co., Ltd.

Yasuko Nanjoh (Y)

Department of Dermatology, Tokyo Medical University.

Katsuhiro Inagaki (K)

Research Center, Nihon Nohyaku Co., Ltd.

Sutthirat Reangchainam (S)

Institute of Dermatology.

Kowit Kampirapap (K)

Institute of Dermatology.

Koichi Makimura (K)

Medical Mycology, Graduate School of Medicine, Teikyo University.

Kazutoshi Harada (K)

Department of Dermatology, Tokyo Medical University.

Ryoji Tsuboi (R)

Department of Dermatology, Tokyo Medical University.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH